These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16935379)

  • 21. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions.
    Chen C; Xie X; Li Y; Zhou C; Song Y; Yan Z; Yang X
    Drug Dev Ind Pharm; 2014 Apr; 40(4):441-51. PubMed ID: 23614831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
    Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
    Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.
    Kanaze FI; Kokkalou E; Niopas I; Barmpalexis P; Georgarakis E; Bikiaris D
    Drug Dev Ind Pharm; 2010 Mar; 36(3):292-301. PubMed ID: 19663560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers.
    Traini D; Young PM; Rogueda P; Price R
    Int J Pharm; 2006 Aug; 320(1-2):58-63. PubMed ID: 16735100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering of nano-crystalline drug suspensions: employing a physico-chemistry based stabilizer selection methodology or approach.
    Nakach M; Authelin JR; Tadros T; Galet L; Chamayou A
    Int J Pharm; 2014 Dec; 476(1-2):277-88. PubMed ID: 25278040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation into the influence of drug-polymer interactions on the miscibility, processability and structure of polyvinylpyrrolidone-based hot melt extrusion formulations.
    Chan SY; Qi S; Craig DQ
    Int J Pharm; 2015 Dec; 496(1):95-106. PubMed ID: 26428633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
    Hugo M; Kunath K; Dressman J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards an understanding of adsorption behaviour in non-aqueous systems: adsorption of poly(vinyl pyrrolidone) and poly(ethylene glycol) onto silica from 2H, 3H-perfluoropentane.
    Paul A; Griffiths PC; Rogueda PG
    J Pharm Pharmacol; 2005 Nov; 57(11):1383-7. PubMed ID: 16259769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the production and the characterization of spray embeddings (author's transl)].
    Kala H; Traue J; Moldenhauer H; Zessin G
    Pharmazie; 1981; 36(2):106-11. PubMed ID: 7232480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel associated hydrogels for nucleus pulposus replacement.
    Thomas J; Lowman A; Marcolongo M
    J Biomed Mater Res A; 2003 Dec; 67(4):1329-37. PubMed ID: 14624520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.